PureTech Health said affiliate company resTORbio has a priced its initial public offering on the Nasdaq exchange. Shares would be issued at an offer price of $15.00 each, resulting in gross proceeds of $85.0m. Following the offering, PureTech Health would hold 9,800,396 shares of resTORbio common stock. At the initial public offering price of $15.00, those shares would have a value of $147.0m.
+5.00p (+3.07%)delayed 17:30PM